Get the Stockscreener App
0.5861
1.16%
-0.0069
After Hours:
.57
-0.0161
-2.75%
Harvard Bioscience Inc stock is traded at $0.5861, with a volume of 177.88K.
It is down -1.16% in the last 24 hours and down -0.19% over the past month.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.
See More
Previous Close:
$0.593
Open:
$0.582
24h Volume:
177.88K
Relative Volume:
0.27
Market Cap:
$26.21M
Revenue:
$106.79M
Net Income/Loss:
$-8.73M
P/E Ratio:
-2.9305
EPS:
-0.2
Net Cash Flow:
$10.81M
1W Performance:
+4.66%
1M Performance:
-0.19%
6M Performance:
+20.35%
1Y Performance:
-52.73%
1-Day Range:
$0.58
$0.5958
1-Week Range:
$0.535
$0.6099
52-Week Range:
$0.2813
$1.26
Harvard Bioscience Inc Stock (HBIO) Company Profile
Name
Harvard Bioscience Inc
Sector
Industry
Phone
(508) 893-8999
Address
84 OCTOBER HILL RD, HOLLISTON, MA
Compare HBIO vs ISRG, BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HBIO
Harvard Bioscience Inc
|
0.5861 | 26.52M | 106.79M | -8.73M | 10.81M | -0.20 |
|
ISRG
Intuitive Surgical Inc
|
499.53 | 177.84B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
182.47 | 51.97B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
83.22 | 40.42B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
MDLN
Medline Inc
|
47.60 | 39.70B | 27.43B | 1.27B | 1.01B | 1.5829 |
|
RMD
Resmed Inc
|
256.29 | 37.72B | 5.40B | 1.49B | 1.78B | 10.12 |
Harvard Bioscience Inc Stock (HBIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-09-25 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Mar-10-23 | Upgrade | The Benchmark Company | Speculative Buy → Buy |
| Jan-07-21 | Upgrade | The Benchmark Company | Speculative Buy → Buy |
| Dec-09-20 | Initiated | Northland Capital | Outperform |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Jul-08-19 | Downgrade | Janney | Buy → Neutral |
| Jan-24-18 | Reiterated | Janney | Buy |
| Jan-23-18 | Reiterated | The Benchmark Company | Buy |
| Nov-17-16 | Initiated | Singular Research | Buy |
| Jul-28-15 | Initiated | The Benchmark Company | Buy |
View All
Harvard Bioscience Inc Stock (HBIO) Latest News
Volume Report: Is Harvard Bioscience Inc exposed to political riskDividend Hike & Advanced Swing Trade Entry Alerts - baoquankhu1.vn
What makes Harvard Bioscience Inc. stock attractive to growth fundsTrade Risk Summary & Free High Accuracy Swing Entry Alerts - mfd.ru
Is Harvard Bioscience Inc. stock forming a triangle patternJuly 2025 Market Mood & Daily Entry Point Alerts - mfd.ru
How Harvard Bioscience Inc. stock reacts to Fed rate cutsJuly 2025 Snapshot & Real-Time Chart Breakout Alerts - mfd.ru
Is Harvard Bioscience Inc. forming a bullish divergenceWeekly Trade Analysis & High Accuracy Swing Trade Signals - mfd.ru
Why Harvard Bioscience Inc. stock could be next big winnerWeekly Profit Summary & Long Hold Capital Preservation Plans - mfd.ru
Harvard Bioscience reports Q4 revenue in line with guidance - Investing.com South Africa
HBIO Posts Strong Q4 Results with Positive Outlook for Future Gr - GuruFocus
Harvard Bioscience reports Q4 revenue in line with guidance By Investing.com - Investing.com Nigeria
Returns Recap: Will Harvard Bioscience Inc face regulatory challengesJuly 2025 Analyst Calls & Expert-Curated Trade Recommendations - baoquankhu1.vn
Harvard Bioscience (HBIO) Faces Strategic Evolution in Life Scie - GuruFocus
Harvard Bioscience Reports Strong Q4 Results and Growth Strategy - Intellectia AI
Harvard Bioscience Reports Preliminary Q4 Results and Outlines Growth Strategy for 2026 - Quiver Quantitative
How Harvard Bioscience aims to bridge lab research to human health - Stock Titan
Harvard Bioscience to Close Holliston Manufacturing Facility as Part of Global Consolidation - Boston Real Estate Times
Harvard Bioscience (NASDAQ:HBIO) Share Price Passes Below 200 Day Moving Average – Here’s Why - Defense World
Aug Chart Watch: Whats next for Harvard Bioscience Inc stockEarnings Overview Report & AI Driven Stock Reports - baoquankhu1.vn
Harvard Bioscience will move Holliston MA manufacturing out of state - MetroWest Daily News
Growth Value: Is Harvard Bioscience Inc stock trending bullishJuly 2025 Big Picture & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
Harvard Bioscience (HBIO) Announces Plan to Offer 9.5 Million Sh - GuruFocus
Harvard Bioscience to close Holliston plant in manufacturing consolidation By Investing.com - Investing.com India
Life sciences instrument manufacturer closing Mass. facility - The Business Journals
What's Going On With Harvard Bioscience Stock Friday?Harvard Bioscience (NASDAQ:HBIO) - Benzinga
Harvard Bioscience (HBIO) Consolidates Manufacturing Operations to Enhance Efficiency - GuruFocus
Harvard Bioscience Announces Major Global Manufacturing Consolidation - TipRanks
Harvard Bioscience to close Holliston plant in manufacturing consolidation - Investing.com
Harvard Bioscience Announces Strategic Consolidation of Manufacturing Operations to Improve Efficiency and Support Long-Term Growth - ChartMill
Aug Ideas: Why is Harvard Bioscience Inc stock going upWeekly Trend Report & Growth Focused Investment Plans - baoquankhu1.vn
Harvard Bioscience Consolidates Manufacturing Operations, Expected to Save $4 Million - Intellectia AI
What’s the fair value of Harvard Bioscience Inc. stock2025 Price Targets & Accurate Entry and Exit Point Alerts - mfd.ru
Hedge Fund Moves: What is Krispy Kreme Incs book value per shareMarket Movers & Weekly High Return Forecasts - baoquankhu1.vn
Harvard Bioscience announces CEO succession plan - MSN
Gains Recap: Will Harvard Bioscience Inc outperform tech stocks2025 Winners & Losers & Short-Term Trading Opportunity Alerts - baoquankhu1.vn
Movement Recap: Is Harvard Bioscience Inc stock trending bullishWeekly Trend Report & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Volatility Watch: Can Harvard Bioscience Inc navigate macro headwindsJuly 2025 Selloffs & Daily Entry Point Trade Alerts - baoquankhu1.vn
Aug Rallies: Is Harvard Bioscience Inc stock a top performer YTD2025 Price Targets & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Investment Report: Is APRE stock a hidden gemJuly 2025 Trade Ideas & Risk Controlled Daily Trade Plans - baoquankhu1.vn
Activity Recap: Whats the fair value of Harvard Bioscience Inc stockQuarterly Performance Summary & Free Daily Entry Point Trade Alerts - baoquankhu1.vn
Harvard Bioscience Lowers Quorum Requirement for Shareholders - TipRanks
Support Test: Is Harvard Bioscience Inc a cyclical or defensive stockWeekly Stock Report & Weekly Consistent Profit Watchlists - baoquankhu1.vn
Harvard Bioscience secures $40M loan agreement - MSN
Is Harvard Bioscience Inc a momentum stock2025 Performance Recap & Community Driven Trade Alerts - baoquankhu1.vn
Aug Highlights: Is Gold Standard Ventures Corp stock good for income investorsM&A Rumor & High Accuracy Trade Signal Alerts - baoquankhu1.vn
Gainers Report: Is Harvard Bioscience Inc stock near bottom after decline2025 Market Trends & Community Consensus Trade Signals - Bộ Nội Vụ
Is Harvard Bioscience Inc. (HBI) stock among top earnings playsBuy Signal & AI Driven Stock Reports - ulpravda.ru
Investment Review: Is Harvard Bioscience Inc HBI stock a momentum leader2025 Support & Resistance & AI Powered Buy/Sell Recommendations - Bộ Nội Vụ
How Harvard Bioscience Inc. stock trades during market volatility2025 Key Lessons & Safe Entry Momentum Stock Tips - Улправда
Is Harvard Bioscience Inc. (HBI) stock a momentum leader2025 Trade Ideas & Weekly Consistent Profit Watchlists - Улправда
How Harvard Bioscience Inc. stock valuations compare to rivalsFed Meeting & Free Verified High Yield Trade Plans - Улправда
Market Catalysts: How Harvard Bioscience Inc. (HBI) stock responds to job market shiftsWeekly Trade Report & Reliable Trade Execution Plans - Улправда
Harvard Bioscience Stock Jump Looks Great, But How Secure Is That Gain? - Trefis
Harvard Bioscience Inc Stock (HBIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.74%
0.34%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):